PQE Group is pleased to announce it has completed and released its 2024 Sustainability Report, which represents a significant ...

PQE Group is a woman-owned leading Life Science consulting firm, providing high-quality solutions in GCP, GLP, GMP, and GDP areas to both industry giants and SMEs worldwide.

GLP-1 agonist semaglutide is the active ingredient in Novo Nordisk's blockbuster weight-loss drug Wegovy, which achieved sales of around $8 billion last year.

The sudden and overwhelming demand for GLP-1 agonists, like Ozempic and Wegovy, has placed immense pressure on pharmaceutical supply chains. What started as a treatment for type 2 diabetes has ...